Correlation Between Bristol Myers and BioRestorative Therapies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and BioRestorative Therapies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and BioRestorative Therapies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and BioRestorative Therapies, you can compare the effects of market volatilities on Bristol Myers and BioRestorative Therapies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of BioRestorative Therapies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and BioRestorative Therapies.

Diversification Opportunities for Bristol Myers and BioRestorative Therapies

-0.46
  Correlation Coefficient

Very good diversification

The 3 months correlation between Bristol and BioRestorative is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and BioRestorative Therapies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioRestorative Therapies and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with BioRestorative Therapies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioRestorative Therapies has no effect on the direction of Bristol Myers i.e., Bristol Myers and BioRestorative Therapies go up and down completely randomly.

Pair Corralation between Bristol Myers and BioRestorative Therapies

Considering the 90-day investment horizon Bristol Myers Squibb is expected to generate 0.25 times more return on investment than BioRestorative Therapies. However, Bristol Myers Squibb is 4.07 times less risky than BioRestorative Therapies. It trades about 0.0 of its potential returns per unit of risk. BioRestorative Therapies is currently generating about -0.01 per unit of risk. If you would invest  6,049  in Bristol Myers Squibb on September 2, 2024 and sell it today you would lose (127.00) from holding Bristol Myers Squibb or give up 2.1% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Bristol Myers Squibb  vs.  BioRestorative Therapies

 Performance 
       Timeline  
Bristol Myers Squibb 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal primary indicators, Bristol Myers showed solid returns over the last few months and may actually be approaching a breakup point.
BioRestorative Therapies 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in BioRestorative Therapies are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, BioRestorative Therapies is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Bristol Myers and BioRestorative Therapies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol Myers and BioRestorative Therapies

The main advantage of trading using opposite Bristol Myers and BioRestorative Therapies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, BioRestorative Therapies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioRestorative Therapies will offset losses from the drop in BioRestorative Therapies' long position.
The idea behind Bristol Myers Squibb and BioRestorative Therapies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets